• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠心病患者中醋酸去氨加压素(DDAVP)输注与静脉闭塞的纤溶反应比较。

Comparison of the fibrinolytic response to desmopressin acetate (DDAVP) infusion versus venous occlusion in patients with coronary artery disease.

作者信息

Duprez D, Baele G, De Buyzere M, Vandenbroecke P, Clement D L

机构信息

Department of Cardiology-Angiology, University Hospital, Ghent, Belgium.

出版信息

Eur Heart J. 1991 Jul;12(7):800-2.

PMID:1909628
Abstract

A 20-min venous occlusion and a desmopressin acetate (DDAVP, 0.4 microgram.Kg-1, 15 min) infusion test have been compared to evaluate fibrinolytic capacity in proven coronary artery disease. Basal values of plasma tissue plasminogen activator (t-PA) activity and antigen and of t-PA inhibitor (PAI) were normally distributed in this patient group. However, after both stimuli, highly significant (P less than 0.005) increases of t-PA antigen and activity have been observed. Renormalization of t-PA levels after DDAVP infusion occurred more rapidly for antigen (120 min) than for activity concentrations (greater than 240 min). A DDAVP infusion test seems more appropriate for evaluation of the fibrinolytic capacity as the induced decrease in PAI level was significant (P less than 0.005) and lasted for at least 240 min, while it was not significant for the venous occlusion test.

摘要

为评估经证实患有冠状动脉疾病患者的纤溶能力,对20分钟静脉阻塞试验和醋酸去氨加压素(DDAVP,0.4微克·千克⁻¹,15分钟)输注试验进行了比较。该患者组血浆组织型纤溶酶原激活物(t-PA)活性、抗原以及t-PA抑制剂(PAI)的基础值呈正态分布。然而,在两种刺激后,均观察到t-PA抗原和活性显著升高(P<0.005)。DDAVP输注后t-PA水平恢复正常,抗原(120分钟)比活性浓度(>240分钟)更快。DDAVP输注试验似乎更适合评估纤溶能力,因为诱导的PAI水平降低显著(P<0.005)且持续至少240分钟,而静脉阻塞试验则不显著。

相似文献

1
Comparison of the fibrinolytic response to desmopressin acetate (DDAVP) infusion versus venous occlusion in patients with coronary artery disease.冠心病患者中醋酸去氨加压素(DDAVP)输注与静脉闭塞的纤溶反应比较。
Eur Heart J. 1991 Jul;12(7):800-2.
2
Different tissue plasminogen activator release in the arm and leg during venous occlusion is equalized after DDAVP infusion.静脉阻塞期间手臂和腿部组织纤溶酶原激活物释放量不同,在输注去氨加压素后可达到平衡。
Thromb Haemost. 1990 Feb 19;63(1):72-5.
3
A dynamic test to investigate potential tissue plasminogen activator activity. Comparison of deamino-8-D-argininevasopressin with venous occlusion in normal subjects and patients.一项用于研究潜在组织纤溶酶原激活物活性的动态试验。正常受试者和患者中去氨基-8-D-精氨酸加压素与静脉闭塞的比较。
J Lab Clin Med. 1988 Jun;111(6):645-53.
4
[Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].[冠状动脉疾病患者纤溶酶原激活物抑制剂活性增加导致纤溶能力下降]
Helv Chir Acta. 1992 Jan;58(4):503-8.
5
Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states.
Blood Coagul Fibrinolysis. 1992 Aug;3(4):389-93.
6
Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.青少年血液纤溶成分的年龄依赖性以及低剂量口服避孕药对青少年凝血和纤溶的影响。
Thromb Haemost. 1988 Dec 22;60(3):361-4.
7
Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease.在年轻冠心病患者中,与体力应激试验相比,静脉闭塞后的纤溶反应。
Thromb Haemost. 1999 Sep;82 Suppl 1:80-4.
8
Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease.血管性血友病中血管壁对去氨加压素和静脉阻塞的分泌反应。
Acta Haematol Pol. 1994;25(3):261-8.
9
Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.人体中内源性组织型纤溶酶原激活剂(t-PA)及其抑制剂的肾脏和肝脏处理过程。
Thromb Haemost. 1988 Jun 16;59(3):404-11.
10
Impaired fibrinolytic response to DDAVP in patients with von Willebrand's disease.血管性血友病患者对去氨加压素的纤溶反应受损。
Nouv Rev Fr Hematol (1978). 1992;34(1):55-60.